Major COVID-19 vaccination changes are coming
One of the last emergency measures from the pandemic-era COVID-19 response is transitioning.
TGA issues two new safety alerts for GLP-1 RA products
The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two...
Friar’s Balsam has a place in modern life
From its 18th century origins to modern uses, Friar's Balsam has continued to be a multi-purpose medicine.
Think you know emergency contraception? Think again
Pharmacists have been supplying emergency contraception in Australia since 2004. Since then, the evidence base and consumer experience surrounding emergency contraception has evolved significantly.
Supporting patients through GLP-1 agonist cessation effects
Glucagon-like peptide 1 (GLP-1) agonists, traditionally used to manage type 2 diabetes, have been increasingly prescribed off-label for weight loss.
There are four GLP-1 agonist...
Goodbye CAL I, hello expanded CAL 18
Merging CAL 18 and CAL I removes duplication and confusion, helping patients receive clearer, more actionable dietary advice.
